Studies side effects of asparaginase drugs in leukemia and lymphoma treatment
Observes short and long term side effects of asparaginase drugs in leukemia or lymphoma patients.
Plain-language title generated from the registry record
Registry title: Real World Asparaginase Therapy Toxicity
Key facts
- Where
- Memphis, United StatesSee the site
Where in United States
- St. Jude Children's Research HospitalMemphis, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- St. Jude Children's Research Hospital
- Trial code
- NCT07008027
- Record updated
- 22 October 2026
- Original description
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.Read full original descriptionShow less
Real World Asparaginase Therapy Toxicity
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.
Inclusion: Diagnosis of acute lymphoblastic leukemia, lymphoblastic lymphoma, or mixed phenotype acute leukemia; Enrolled on INITIALL and no more than 10 days after initiation of post-INITIALL therapy; Post-INITIALL therapy is:; Standard of Care (SOC)/Non Protocol Treatment Plan (NPTP) as per Total therapy or; SJALL23T and not scheduled to receive venetoclax.
Exclusion: Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.